Josephine Bunch

Josephine Bunch is a fellow at the National Physical Laboratory. She is Chair of Biomolecular Mass Spectrometry at Imperial College London and the Co-Director of the National Centre of Excellence in Mass Spectrometry Imaging.

Bunch completed a PhD sponsored by Pfizer at Sheffield Hallam University in 2005.^[1] Her thesis, "Detection and imaging of pharmaceutical compounds in skin by MALDI-MS", used mass spectrometry.^[2]

Bunch was a postdoctoral researcher at the University of Sheffield, where she was awarded an Enterprise Fellowship to commercialise imaging using mass spectrometry.^[1] She joined the University of Birmingham, leading a large multi-disciplinary group using MALDI Mass spectrometry.^{[3] [4]} She remains an honorary senior research fellow at the University of Birmingham.^[5] She also holds a Chair in Biomolecular Mass Spectrometry at Imperial College London.^[6]

She joined the National Physical Laboratory in 2013, where she became responsible for research in MALDI metrology.^{[4] [7]} In 2017 Bunch was funded by Cancer Research UK's Grand Challenge to map tumours at a molecular and cellular level.^[8] She came up with the idea when listening to a BBC Radio 4 program about the Cancer Research UK Grand Challenges.^[9] The investment was worth 16ドル million, and uses mass spectrometry imaging techniques to study breast, bowel and pancreatic tumours in "unprecedented detail.^{[10] [11] [12] [13] [14]} She spoke about the project at the Hay Festival and presented their project at the Royal Society Summer Exhibition.^{[15] [16] [17]}

She is part of a COST (European Cooperation in Science and Technology) Action on mass spectrometry imaging.^{[18] [3]}

• Living people
• Alumni of Sheffield Hallam University
• British women physicists
• Fellows of the National Physical Laboratory (United Kingdom)
• People educated at Headington School

• Articles with short description
• Short description matches Wikidata
• Articles with hCards
• Year of birth missing (living people)